People: Genomic Health Inc (GHDX.O)

GHDX.O on Nasdaq

28.08USD
21 Aug 2014
Price Change (% chg)

$0.05 (+0.18%)
Prev Close
$28.03
Open
$28.04
Day's High
$28.31
Day's Low
$27.78
Volume
107,429
Avg. Vol
147,439
52-wk High
$37.24
52-wk Low
$23.90

Search Stocks

Graham, Ginger 

Brief Biography

Ms. Ginger L. Graham is Independent Director of Genomic Health, Inc. She has served as Faculty at Harvard Business School since October 2009 and as President and Chief Executive Officer of Two Trees Consulting, a healthcare and executive leadership consulting firm, since November 2007. Ms. Graham was Chief Executive Officer of Amylin Pharmaceuticals, Inc., a biopharmaceutical company, from September 2003 to March 2007, and served as Amylin's President from September 2003 to June 2006. From 1994 to 2003, Ms. Graham held various positions with Guidant Corporation, including Group Chairman, Office of the President, President of the Vascular Intervention Group, and Vice President. From 1979 to 1994, Ms. Graham held various positions with Eli Lilly and Company, including President and Chief Executive Officer of Advanced Cardiovascular Systems, Inc. Ms. Graham currently serves as a director of Walgreen Co. and a number of privately held companies. Ms. Graham served as a director of Amylin Pharmaceuticals, Inc. from November 1995 to May 2009. Ms. Graham holds a B.S. in Agricultural Economics from the University of Arkansas and an M.B.A. from Harvard University.

Basic Compensation

Total Annual Compensation, Long-Term Incentive Plans, All Other, Fiscal Year Total,
-- -- -- --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Kimberly Popovits

2,140,180

G. Bradley Cole

1,448,860

Steven Shak

1,300,320

Julian Baker

--

Henry Fuchs

--

Felix Baker

--
As Of 30 Dec 2013
Search Stocks